Sage Advises Vesselon on Partnering Its Microbubble Technology for Improving Delivery of Cancer Drug

Sage has been appointed by Vesselon based in Norwalk Connecticut USA. Vesselon uses patents from Columbia University on the use of microbubbles and ultrasound to improve the delivery and pharmacokinetics of cancer drugs to enhance their efficacy and improve their useful life from an IP point of view

Vesselon’s technologies for improved drug delivery and pharmacokinetics are broadly applicable to many drugs.